← Back to Search

Behavioral Intervention

CALM Therapy for Primary Brain Tumor Distress

N/A

Waitlist Available

Led By Terri S Armstrong, C.R.N.P.

Research Sponsored by National Cancer Institute (NCI)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects with histological or imaging confirmation of PCNST who are undergoing standard of care or experimental treatment

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 and 6 months compared to baseline

Awards & highlights

Study Summary

This trial is testing whether the CALM therapy can help people with a CNST suffering from distress. English-speaking adults with a CNST may be eligible. The study will be done by smartphone, computer, or tablet.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You have confirmed brain or spinal cord cancer and are currently receiving standard treatment or taking part in a research study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 and 6 months compared to baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 and 6 months compared to baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 and 6 months compared to baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

feasibility of implementing CALM remotely

reduction of anxiety score using the Death and Dying Distress Scale (DADDS)

reduction of depressive symptoms using the PROMIS-Depression scale in PCNST participants

Trial Design

1Treatment groups

Experimental Treatment

Group I: Arm 1Experimental Treatment1 Intervention

Remote CALM therapy for participants with newly or recurrent PCNST

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)Lead Sponsor

13,654 Previous Clinical Trials

40,933,140 Total Patients Enrolled

81 Trials studying Depression

66,094 Patients Enrolled for Depression

Terri S Armstrong, C.R.N.P.Principal InvestigatorNational Cancer Institute (NCI)

5 Previous Clinical Trials

10,618 Total Patients Enrolled

Media Library

CALM Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04852302 — N/A

Depression Clinical Trial 2023: CALM Therapy Highlights & Side Effects. Trial Name: NCT04852302 — N/A

CALM Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04852302 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for new participants to enter this clinical research?

"Data hosted on clinicaltrials.gov indicates that this medical trial, which was first made available on August 11th 2021, is not currently enrolling patients. However, there are presently 1529 different studies seeking participants in the United States of America."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Managing Cancer and Living Meaningfully (CALM) Therapy in Individuals Diagnosed With a Primary Brain Tumor

2021. "Managing Cancer and Living Meaningfully (CALM) Therapy in Individuals Diagnosed With a Primary Brain Tumor". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04852302.